Antidepressant-induced reduction in betel-quid use in patients with depression: A pioneer clinical study

Betel-quid is commonly used around the world and is listed as a Group I carcinogen. Prior research has suggested a possible association between antidepressants and betel-quid use. We aimed to clarify the effects of antidepressant therapy in betel-quid chewers in the population of patients with depre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Chung-Chieh, Lee, Chien-Hung, Chung, Chia-Min, Nithiyanantham, Srinivasan, Lane, Hsien-Yuan, Ko, Ying-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
6500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946344/
https://www.ncbi.nlm.nih.gov/pubmed/31895834
http://dx.doi.org/10.1097/MD.0000000000018672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946344/
https://www.ncbi.nlm.nih.gov/pubmed/31895834
http://dx.doi.org/10.1097/MD.0000000000018672

Ejemplares similares